U.S. Markets close in 1 hr 53 mins
  • S&P 500

    3,634.48
    +56.89 (+1.59%)
     
  • Dow 30

    30,033.77
    +442.50 (+1.50%)
     
  • Nasdaq

    12,037.24
    +156.61 (+1.32%)
     
  • Russell 2000

    1,854.16
    +35.86 (+1.97%)
     
  • Crude Oil

    44.92
    +1.86 (+4.32%)
     
  • Gold

    1,803.40
    -34.40 (-1.87%)
     
  • Silver

    23.29
    -0.34 (-1.45%)
     
  • EUR/USD

    1.1882
    +0.0037 (+0.3089%)
     
  • 10-Yr Bond

    0.8720
    +0.0150 (+1.75%)
     
  • Vix

    21.99
    -0.67 (-2.96%)
     
  • GBP/USD

    1.3360
    +0.0038 (+0.2832%)
     
  • USD/JPY

    104.5400
    +0.0520 (+0.0498%)
     
  • BTC-USD

    19,159.62
    +707.65 (+3.84%)
     
  • CMC Crypto 200

    380.34
    +10.59 (+2.86%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,165.59
    +638.22 (+2.50%)
     

Veracyte: 3Q Earnings Snapshot

·1 min read

SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Monday reported a loss of $4.1 million in its third quarter.

The South San Francisco, California-based company said it had a loss of 8 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The molecular diagnostic company posted revenue of $31.1 million in the period.

Veracyte shares have climbed 25% since the beginning of the year. In the final minutes of trading on Monday, shares hit $35, a rise of 53% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT